- Home
- CBOE vs DXCM Comparison
CBOE vs DXCM Comparison
Compare CBOE & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CBOE | DXCM |
|---|---|---|
| Founded | 1973 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.8B | 28.1B |
| IPO Year | 2010 | 2005 |
Fundamental Metrics
Financial Performance| Metric | CBOE | DXCM |
|---|---|---|
| Price | $281.61 | $72.69 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 21 |
| Target Price | ★ $289.44 | $85.33 |
| AVG Volume (30 Days) | 1.3M | ★ 6.1M |
| Earning Date | 05-01-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.94% | N/A |
| EPS Growth | 44.52 | ★ 47.18 |
| EPS | ★ 3.66 | 0.51 |
| Revenue | ★ $2,229,100,000.00 | N/A |
| Revenue This Year | N/A | $14.46 |
| Revenue Next Year | $3.54 | $12.31 |
| P/E Ratio | ★ $77.97 | $142.30 |
| Revenue Growth | ★ 239.31 | N/A |
| 52 Week Low | $218.14 | $54.11 |
| 52 Week High | $371.18 | $89.07 |
Technical Indicators
Market Signals| Indicator | CBOE | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 30.59 | 63.88 |
| Support Level | $276.64 | $62.86 |
| Resistance Level | $304.22 | $74.08 |
| Average True Range (ATR) | 13.25 | 2.79 |
| MACD | -10.46 | 0.38 |
| Stochastic Oscillator | 12.31 | 76.06 |
Price Performance
Historical ComparisonAbout CBOE Cboe Global Markets Inc.
Founded in 1973, Cboe controls the largest option exchange in the US, which provides around 60% of the firm's revenue. The company is best known for its proprietary S&P 500 and VIX index options, which it offers through an exclusive contract with S&P Global. The firm moved into US and European equities through the $3.4 billion acquisition of BATS in 2017. Cboe has continued to look to expand internationally, using acquisitions to build a presence in both Canada and Australia.
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.